Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Current status of newborn screening in Southeastern and Central Europe
Avtorji:ID Požun, Nika (Avtor)
ID Perko, Daša (Avtor)
ID Anastasovska, Violeta (Avtor)
ID Battelino, Tadej (Avtor)
ID Drole Torkar, Ana (Avtor)
ID Mlinarič, Matej (Avtor)
ID Remec, Žiga Iztok (Avtor)
ID Repič-Lampret, Barbka (Avtor)
ID Trampuž, Domen (Avtor)
ID Žerjav-Tanšek, Mojca (Avtor)
ID Grošelj, Urh (Avtor), et al.
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (749,60 KB)
MD5: BD063A7572D99CEF1A1539EBC137AA43
 
URL URL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2409-515X/12/1/14
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Newborn screening (NBS) is a well-established public health program that enables early detection and treatment of rare disorders in newborns, preventing severe complications or death. Despite its recognized importance, the scope and implementation of NBS programs vary across Southeastern (SE) and Central Europe. This study aimed to evaluate the current status of NBS in 16 countries of SE and Central Europe and assess progress since the previous survey in 2021. A structured questionnaire was distributed to national experts between April and December 2025, collecting data on program organization, coverage, diseases included, laboratory methods, confirmatory testing, consent practices, and future expansion plans. All countries reported universal screening for congenital hypothyroidism, except Kosovo, where a national NBS is in the process of being established. Expanded NBS using tandem mass spectrometry was available in Austria, Bulgaria, Croatia, Cyprus, Greece, Hungary, North Macedonia, Romania, and Slovenia. Spinal muscular atrophy screening became universal in Austria, Croatia, Hungary, Serbia, and Slovenia. Most countries reported plans for further expansion, with congenital adrenal hyperplasia, severe combined immunodeficiency, spinal muscular atrophy, and cystic fibrosis being the most frequently targeted conditions. Although notable infrastructural progress has been achieved, financial constraints, lack of staff, and organizational barriers remain key challenges. The study’s assessment of program effectiveness was further limited by the absence of region-wide systems for capturing end-to-end performance indicators, such as the age of the infant at treatment initiation or missed cases. Regional collaboration and adoption of best practices are therefore vital to ensure equitable access and continuous advancement of NBS programs.
Ključne besede:newborn screening, NBS, Southeastern Europe, Central Europe, neonatal screening, expanded NBS program
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2026
Št. strani:str. 1-23
Številčenje:Vol. 12, issue 1, [article no. ] 14
PID:20.500.12556/DiRROS-28010 Novo okno
UDK:616-053.2
ISSN pri članku:2409-515X
DOI:10.3390/ijns12010014 Novo okno
COBISS.SI-ID:270681603 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 6. 3. 2026;
Datum objave v DiRROS:06.03.2026
Število ogledov:79
Število prenosov:36
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:International journal of neonatal screening
Skrajšan naslov:Int. j. neonatal screen.
Založnik:MDPI AG
ISSN:2409-515X
COBISS.SI-ID:525322521 Novo okno

Gradivo je financirano iz projekta

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P3-0343-2022
Naslov:Etiologija, zgodnje odkrivanje in zdravljenje bolezni pri otrocih in mladostnikih

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Nazaj